Professor Andrea Henle earned a B.A. in biochemistry from the College of St. Benedict and a Ph.D. in biomedical sciences-immunology from the Mayo Clinic.

Prof. Henle joined the Carthage faculty in fall 2015 after a year as a visiting professor at Bard College. She previously completed a postdoctoral research and teaching fellowship at Massachusetts Institute of Technology and taught courses in biology at MIT, Harvard University, Carleton College, and in Singapore.

Her research focuses on the intersection of cell biology, cancer, and immunology. She uses both the zebrafish model organism and cancer cell lines to model melanoma and understand the cellular events that lead to cancer initiation and progression. She is particularly interested in discovering ways to get the immune system to recognize and fight tumors.

She has authored publications in journals such as Pigment Cell and Melanoma Research, the Journal of Immunology, and the Journal of Visualized Experiments, and is a co-inventor on a patent for a peptide that is being explored as a possible vaccine to prevent breast cancer recurrence.

Technology, Science, Cancer, Health, Healthcare, Biologists, Biology Chemistry,